SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Sonoma Pharmaceuticals (SNOA) Stock: Buy, Sell, or Hold?
$1.24
+0.10 (+8.77%)
▲
5d:
+11.71%
30d:
+5.08%
90d:
-7.46%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (32%)
Quality Score
47/100
Position
EXTENDED
30-Day Fair Range
$1.11 – $1.20
Position: EXTENDED
Forward P/E & Valuation
-2.2x
Next 12M consensus est.
Wall Street Target
$12.00
+867.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.05 / $1.30
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SNOA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When SNOA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SNOA is currently trading at $1.24, which is considered extended relative to its 30-day fair value range of $1.11 to $1.20.
Technical Outlook: Technically, SNOA is showing sideways momentum. Immediate support is located at $1.05, while resistance sits at $1.30. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: SNOA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+867.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNOA is showing sideways momentum. Immediate support is located at $1.05, while resistance sits at $1.30. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: SNOA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+867.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.11 -
$1.20
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
31.6%
Trading Range & Key Levels
30-Day Trading Range
$1.11 -
$1.20
Current vs Trading Range
EXTENDED
Support Level
$1.05
Resistance Level
$1.30
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.8%)
- BULLISH: Trading 867.7% below Wall St target ($12.00)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.21
Wall Street Target
$12.00
(+867.7%)
Revenue Growth (YoY)
59.6%
Profit Margin
-10.3%
Share SNOA Analysis
Share this live SNOA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SNOA)
Bullish
5 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Sonoma Pharmaceuticals reported Q2 2027 financial results, delivering a net income before taxes for the first time in the company's history, with a 28% increase in total revenue and a 93% increase in U.S. revenue.
Key Retail Themes:
positive financial results
growing revenue
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:33 PM ET
Data refreshes hourly during market hours. Next update: 10:33 PM
Data refreshes hourly during market hours. Next update: 10:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNOA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SNOA Research Pages
